Requests for Proposals in Medical Research from various private funding sources are posted below. These are updated regularly with grants with the shortest deadlines or that require letters of intent posted first.
Contact the Office of Research and Sponsored Programs for submission assistance, eligibility questions, or other grant funding questions.
Contact Stephen Schafer, Ph.D., Executive Director of Development, UAMS Office of Corporations and Foundations, SJSchafer@uams.edu for questions about a specific corporation or foundation.
Alzheimer’s Drug Discovery Foundation Seeks Proposals for New Alzheimer’s Drug Trials
POSTED: January 13, 2015
The Alzheimer’s Drug Discovery Foundation is accepting proposals for clinical trials of innovative drugs to treat Alzheimer’s disease. Award grants of up to $1.5 million for biomarker-based pilot clinical trials of Alzheimer drugs at the proof-of-concept phase. Particularly interested in projects aimed at testing drugs approved for other indications in Alzheimer’s disease, as well as therapies that address energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury, and the blood-brain barrier interface. Nonprofit academic institutions and for-profit biotechnology companies are eligible to apply. Deadlines in 2015 for full proposals are March 10, June 16, September 22, and December 10. Letters of Intent are required at least two weeks prior to the application deadline.
SFARI Invites Applications for Explorer Awards
POSTED: December 15, 2015
DEADLINE: Rolling (response time as early as thirty days)
The Simons Foundation Autism Research Initiative seeks to improve the understanding, diagnosis, and treatment of autism spectrum disorders by funding novel research of the highest quality and relevance. SFARI is inviting applications for its SFARI Explorer Awards program, which is designed to enhance the foundation’s existing support of autism research by providing timely resources to focused experiments highly relevant to its mission. The foundation seeks to increase the scientific community’s engagement and understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. Explorer Awards are intended to provide resources to support the exploratory stage of projects with the potential to develop into competitive applications for subsequent larger-scale funding by SFARI or other organizations. Novel, high-risk/high-impact proposals are encouraged. Applications from investigators who are new to the field of autism but who have expertise that could be brought to bear on this complex disorder are encouraged.
One-year grants of up to $70,000, including indirect costs, will be awarded. All applicants and key collaborators must hold a Ph.D., M.D., or equivalent and have a faculty position or the equivalent at a college, university, medical school, or other research facility. No citizenship or country requirements.
Medical Toxicology Foundation Issues RFP for Research and Teaching Awards
POSTED: September 19, 2016
DEADLINE: February 15, 2017
The Medical Toxicology Foundation is accepting applications for its 2017 Research and Teaching Awards. The foundation will award a grant or grants totaling up to $20,000 over one to two years in support of innovative projects that support its mission to advance understanding, enhance patient care, and improve the dissemination of knowledge with respect to toxic exposures.
Current research and education priorities of the foundation include support for early-career investigators (fellows and young faculty with less than five years post-fellowship training) and support for the development of innovative approaches to the delivery of medical toxicology education to healthcare providers and the lay public.
Bay Area Lyme Foundation Seeks Applications for Emerging Leader Award
POSTED: October 10, 2016
DEADLINE: February 15, 2017
The Bay Area Lyme Foundation is seeking applications for its Emerging Leader Award program.The annual program recognizes up-and-coming researchers bringing new approaches and creative thinking to the field of Lyme disease. A grant of $100,000 will support a new and innovative project and is designed to attract aspiring new scientific talent to the field of Lyme Disease.
To be eligible, applicants must be early in their careers and have clearly focused research objectives. Applicants must also be affiliated with an academic or research institution, have professional tenure at the postdoctoral level, and be able to demonstrate professional and scientific leadership in the biological and medical sciences.
In 2017, the foundation is offering additional ELA grants at the $250,000 level to veteran scientific talent with the title of associate professor or above who have not previously worked in Lyme disease research.
Applicants must be affiliated with an academic institution or corporate equivalent in the U.S. and propose to apply their work in other fields to therapeutics or diagnostics in Lyme disease.
American Society for Reproductive Medicine Invites Applications From Junior Investigators
POSTED: August 8, 2016
DEADLINE: March 7, 2017
The American Society for Reproductive Medicine seeks applications for its Research Grants program, an annual program designed to facilitate the research of new investigators; provide bridge funds for projects; and foster the development of innovative research. ASRM research grants of up to $50,000 will be awarded for project expenses, technical assistance, patient expenses, research supplies, and durable laboratory equipment. Innovative projects or projects that have previously been funded by other sources and are in need of bridge funding are appropriate. Proposals from junior faculty, particularly those in their first 3 years of faculty appointment, will receive priority. Applicants must have earned an M.D. and/or Ph.D. and/or D.O. and/or D.V.M. degree or their equivalent; be an independent investigator who has completed his/her training and has a full-time faculty/research staff appointment as of July 1, 2016; and have been an active or associate member of ASRM since at least July 1, 2015.
PSC Partners Seeking a Cure Invites Applications for Research Grants
POSTED: October 3, 2016
DEADLINE: May 1, 2017
PSC Partners Seeking a Cure is a nonprofit foundation whose mission is to provide education and support to patients with primary sclerosing cholangitis, their families, and their caregivers and raise funds to research the causes, treatments, and cures for PSC, an autoimmune disease that causes the bile ducts inside and outside the liver to become scarred, narrowed, and eventually blocked.
The foundation offers grants of up to $60,000 over two years for research projects that address an important and novel, basic, or clinical research question related to PSC and closely allied diseases (such as inflammatory bowel diseases, ulcerative colitis, or Crohn’s disease) as they relate to PSC.
Preference will be given to projects that have the potential to identify a cure for the disease and/or identify novel therapies that may significantly delay the time to liver transplantation, prevent disease recurrence following liver transplantation, and/or improve quality of life for those with PSC.
The foundation recognizes that much fundamental research is necessary to discover the environmental factors that may trigger the disease in genetically susceptible individuals and would like to encourage research proposals aimed at identifying the gene-environment interactions contributing to disease initiation and progression. The foundation also is interested in funding research that explores PSC-related diseases (UC, and Crohn’s disease) and the ways that they impact, enable, or perhaps cause PSC.
Research that will be complementary to the goals and objectives of the International PSC Study Group, including investigation of the functional roles of genes associated with susceptibility to and severity of PSC, also is encouraged.